Sorel N - Search Results

1

Evaluation of beta-catenin activating mutations in chronic myeloid leukemia.

Chomel JC, Villalva C, Sorel N, Chazelas F, Guilhot F, Turhan AG. Chomel JC, et al. Among authors: sorel n. Leuk Res. 2008 May;32(5):838-9. doi: 10.1016/j.leukres.2007.09.003. Epub 2007 Oct 30. Leuk Res. 2008. PMID: 17977597 No abstract available.

2

p14ARF, p15INK4b, and p16INK4a methylation status in chronic myelogenous leukemia.

Kusy S, Cividin M, Sorel N, Brizard F, Guilhot F, Brizard A, Larsen C, Roche J. Kusy S, et al. Among authors: sorel n. Blood. 2003 Jan 1;101(1):374-5. doi: 10.1182/blood-2002-09-2834. Blood. 2003. PMID: 12485942 Free article. No abstract available.

3

p190(BCR-ABL) rearrangement as a secondary change in a case of acute myelo-monocytic leukemia with inv(16)(p13q22).

Cividin M, Brizard F, Sorel N, Renaud M, Guilhot F, Brizard A. Cividin M, et al. Among authors: sorel n. Leuk Res. 2004 Jan;28(1):97-9. doi: 10.1016/s0145-2126(03)00161-9. Leuk Res. 2004. PMID: 14630086

4

Evidence of ABL-kinase domain mutations in highly purified primitive stem cell populations of patients with chronic myelogenous leukemia.

Sorel N, Bonnet ML, Guillier M, Guilhot F, Brizard A, Turhan AG. Sorel N, et al. Biochem Biophys Res Commun. 2004 Oct 22;323(3):728-30. doi: 10.1016/j.bbrc.2004.08.169. Biochem Biophys Res Commun. 2004. PMID: 15381060

5

Double-gradient-denaturing-gradient gel electrophoresis for mutation screening of the BCR-ABL tyrosine kinase domain in chronic myeloid leukemia patients.

Sorel N, Chazelas F, Brizard A, Chomel JC. Sorel N, et al. Clin Chem. 2005 Jul;51(7):1263-6. doi: 10.1373/clinchem.2004.047274. Clin Chem. 2005. PMID: 15976107 No abstract available.

6

Millot F, Brizard F, Sorel N, Preudhomme C, Cividin M, Guilhot F, Brizard A. Millot F, et al. Among authors: sorel n. Leuk Lymphoma. 2005 Jun;46(6):925-7. doi: 10.1080/10428190500052248. Leuk Lymphoma. 2005. PMID: 16019540

7

Expression of the cell cycle regulators p14(ARF) and p16(INK4a) in chronic myeloid leukemia.

Cividin M, Ayrault O, Sorel N, Séité P, Brizard F, Blanchet O, Mahon FX, Guilhot F, Larsen C, Chomel JC, Brizard A. Cividin M, et al. Among authors: sorel n. Leuk Res. 2006 Oct;30(10):1273-8. doi: 10.1016/j.leukres.2006.02.002. Epub 2006 Mar 14. Leuk Res. 2006. PMID: 16533530

8

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(phi)-LMC GROUP).

Nicolini FE, Corm S, Lê QH, Sorel N, Hayette S, Bories D, Leguay T, Roy L, Giraudier S, Tulliez M, Facon T, Mahon FX, Cayuela JM, Rousselot P, Michallet M, Preudhomme C, Guilhot F, Roche-Lestienne C. Nicolini FE, et al. Among authors: sorel n. Leukemia. 2006 Jun;20(6):1061-6. doi: 10.1038/sj.leu.2404236. Leukemia. 2006. PMID: 16642048

9

Sequential emergence of ABL-kinase mutations with loss of unmutated BCR-ABL allele during targeted therapies of CML.

Sorel N, Roy L, Martineau G, Guilhot F, Turhan AG, Chomel JC. Sorel N, et al. Blood. 2006 Sep 1;108(5):1782-3. doi: 10.1182/blood-2006-03-011668. Blood. 2006. PMID: 16926302 Free article. No abstract available.

10

Neutrophil gelatinase-associated lipocalin expression in chronic myeloid leukemia.

Villalva C, Sorel N, Bonnet ML, Guilhot J, Mayeur-Rousse C, Guilhot F, Chomel JC, Turhan AG. Villalva C, et al. Among authors: sorel n. Leuk Lymphoma. 2008 May;49(5):984-8. doi: 10.1080/10428190801942360. Leuk Lymphoma. 2008. PMID: 18464118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page